Literature DB >> 23189333

Safety of thimerosal in vaccines: for whom and how many doses?

Jose G Dorea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 23189333     DOI： 10.2515/therapie/2011027

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  1 in total

1.  Thimerosal compromises human dendritic cell maturation, IL-12 production, chemokine release, and T-helper polarization.

Authors:  Emily Loison; Marie-Lise Gougeon
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.